EORTC Groups Annual Meeting - EGAM2011 Plenary Session
This meeting of all clinical and translational EORTC groups has given the opportunity to all participants to contribute to the scientific activities of each group irrespective of the primary group affiliation. Groups' oriented sessions have been conducted in parallel with a review of groups' ongoing studies as well as reporting the status of protocols under development and new proposals.
Presentations
Current Plans for Transformation of NCI Cooperative Group Program and Impact on Transatlantic Cooperation with EORTC Plenary Session
Molecular Driven Clinical Trials: The Network of Core Institutions (NOCI) Perspectives Plenary session
The Innovative Medicines Initiative: towards new models of collaborative research across Europe Plenary Session
Evolution in the design and conduct of cancer clinical trials: where do we stand? Plenary Session
Presidential address Plenary session
Involvement of patients advocacy in clinical trials decision making Plenary Session - Round Table
EORTC Biobanking strategy: dream, necessity, reality Plenary Session
What a good Translational Research project should contain? Plenary Session
Infos
| Date | March 03, 2011 |
|---|---|
| Program-Link: | http://www.eortc.be/seminar/educationpgm/EGAM_2011/EGAM_2011_Plenary_Session.pdf |
| Website: | http://www.eortc.be/seminar/educationpgm/EGAM_2011/Programs.htm |
| Location: | Crowne Plaza Brussels - Le Palace; |
| Category: | Medicine; |
Latest Presentations
Videos are not working? If the videos are not working on your computer, make sure you have installed the latest Flash Player and javascript is enabled in your browser.
Latest Congresses
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our Terms of use. Warning: Some websites may contain content of an adult nature. These pages are designed for ADULTS only.